DiaMedica Therapeutics

DMAC

Capitalización de mercado USD 474 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Cooperman Leon G	USD 2.26 M	–	–	–
2	2 Vanguard Group Malvern, Pennsylvania	USD 2.04 M	+USD 18.6 k	+5,800	+0.7%
3	ACM 3 Altium Capital Management New York	USD 1.28 M	+USD 1.59 M	+496,000	Nuevas
4	PAPAIJV 4 Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas	USD 1.21 M	+USD 466 k	+145,000	+45%
5	5 Bleichroeder LP New York	USD 574 k	-USD 231 k	-71,800	-24%
6	6 Geode Capital Management Boston, Massachusetts	USD 565 k	+USD 109 k	+33,908	+18%
7	7 EAM Investors Solana Beach, California	USD 548 k	-USD 186 k	-57,907	-21%
8	8 Jacob Asset Management of New York Hermosa Beach, California	USD 435 k	-USD 96.4 k	-30,000	-15%
9	9 First Manhattan New York	USD 296 k	-USD 32.1 k	-10,000	-8%
10	10 Aristides Capital Louisville, Kentucky	USD 274 k	+USD 342 k	+106,333	Nuevas
11	11 BlackRock New York	USD 262 k	+USD 95.7 k	+29,810	+41%
12	12 Morgan Stanley New York	USD 242 k	+USD 118 k	+36,700	+64%
13	13 Northern Trust Chicago, Illinois	USD 231 k	+USD 24.2 k	+7,540	+9%
14	14 State Street Boston, Massachusetts	USD 172 k	–	–	–
15	15 Catalyst Financial Partners Boston, Massachusetts	USD 93.6 k	–	–	–
16	16 Bank of New York Mellon New York	USD 89.3 k	-USD 4.1 k	-1,277	-4%
17	17 Millennium Management New York	USD 74 k	+USD 92.1 k	+28,672	Nuevas
18	18 Marshall Wace London, United Kingdom	USD 69 k	+USD 85.9 k	+26,745	Nuevas
19	19 Stonebridge Capital Advisors St Paul, Minnesota	USD 51.6 k	+USD 64.2 k	+20,000	Nuevas
20	20 Dimensional Fund Advisors Austin, Texas	USD 43.8 k	–	–	–
21	21 Citadel Advisors Miami, Florida	USD 40.9 k	+USD 25.6 k	+7,956	+101%
22	22 BNP Paribas Financial Markets Paris, France	USD 36.1 k	+USD 13.5 k	+4,200	+43%
23	23 Charles Schwab San Francisco, California	USD 34.2 k	–	–	–
24	24 MassMutual Private Wealth & Trust Windsor, Connecticut	USD 12.4 k	–	–	–
25	25 US Bancorp Minneapolis, Minnesota	USD 11.2 k	–	–	–

DiaMedica Therapeutics DMAC Capitalización de mercado USD 474 M

DiaMedica Therapeutics

DMAC

Capitalización de mercado USD 474 M